recruitment, contract and temporary staffing, and court reporting services. Our client is a well-known FMCG company. To cope... in Business or any discipline is highly preferable 3 years relevant experience of sales or account management in FMCG industry...
business partners Assist in Ad hoc project Do you have experience in Retail Industry / FMCG? University graduate... in marketing, communication, or related fields 1-2 years of experience in Retail Industry/FMCG/Marketing & Partnership/Shopping...
(FMCG) and High-Fashion market. Manage deployment projects per Centric’s Agile deployment methodology, delivering customer... years. Acquire and disseminate FMCG domain and system integration best practices and provide customer scenario...
efficiency within the HR function. Leading FMCG organisationCommercial office Bachelor's degree in Human Resources... organisations Industry experience in the FMCG/ retail sectors is a MUST Ability to demonstrate strong commercial sense and think...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »